Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry

JACC: Clinical Electrophysiology

Volumn 2, Issue 3, 2016, Pages 355-363

  Pandey, Ambarish ^a   Gersh, Bernard J ^b   McGuire, Darren K ^a   Shrader, Peter ^c   Thomas, Laine ^c   Kowey, Peter R ^d   Mahaffey, Kenneth W ^e   Hylek, Elaine ^f   Sun, Shining ^a   Burton, Paul ^g   Piccini, Jonathan ^c   Peterson, Eric ^c   Fonarow, Gregg C ^h  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Mayo Clinic   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^h UCLA MEDICAL CENTER   (United States)

Author keywords

atrial fibrillation; body mass index; mortality; stroke

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE CONTROL; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP DISORDERED BREATHING; THROMBOEMBOLISM;

EID: 84979205219     PISSN: 2405500X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacep.2015.12.001     Document Type: Article

References (30)

1. 1 Fuster, V., Ryden, L.E., Cannom, D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 48 (2006), e149–e246.
2. 2 Benjamin, E.J., Wolf, P.A., D'Agostino, R.B., Silbershatz, H., Kannel, W.B., Levy, D., Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 (1998), 946–952.
3. 3 Kim, M.H., Johnston, S.S., Chu, B.C., Dalal, M.R., Schulman, K.L., Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 4 (2011), 313–320.
4. 4 Piccini, J.P., Hammill, B.G., Sinner, M.F., et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes 5 (2012), 85–93.
5. 5 Go, A.S., Mozaffarian, D., Roger, V.L., et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 129 (2014), e28–e292.
6. 6 Go, A.S., Hylek, E.M., Phillips, K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001), 2370–2375.
7. 7 Chugh, S.S., Blackshear, J.L., Shen, W.K., Hammill, S.C., Gersh, B.J., Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 37 (2001), 371–378.
8. 8 Smith, J.G., Platonov, P.G., Hedblad, B., Engstrom, G., Melander, O., Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 25 (2010), 95–102.
9. 9 Tedrow, U.B., Conen, D., Ridker, P.M., et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol 55 (2010), 2319–2327.
10. 10 Wang, T.J., Parise, H., Levy, D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004), 2471–2477.
11. 11 Tsang, T.S., Barnes, M.E., Miyasaka, Y., et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 29 (2008), 2227–2233.
12. 12 Angeras, O., Albertsson, P., Karason, K., et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 34 (2013), 345–353.
13. 13 Curtis, J.P., Selter, J.G., Wang, Y., et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165 (2005), 55–61.
14. 14 Eisenstein, E.L., McGuire, D.K., Bhapkar, M.V., et al. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. Am J Med 118 (2005), 981–990.
15. 15 Fonarow, G.C., Srikanthan, P., Costanzo, M.R., et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153 (2007), 74–81.
16. 16 Piccini, J.P., Fraulo, E.S., Ansell, J.E., et al. Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J 162 (2011), 606–612.e1.
17. 17 Kirchhof, P., Auricchio, A., Bax, J., et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. EuroPace 9 (2007), 1006–1023.
18. 18 Spertus, J., Dorian, P., Bubien, R., et al. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol 4 (2011), 15–25.
19. 19 Ardestani, A., Hoffman, H.J., Cooper, H.A., Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 106 (2010), 369–373.
20. 20 Badheka, A.O., Rathod, A., Kizilbash, M.A., et al. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 123 (2010), 646–651.
21. 21 Wang, J., Yang, Y.M., Zhu, J., et al. Overweight is associated with improved survival and outcomes in patients with atrial fibrillation. Clin Res Cardiol 103 (2014), 533–542.
22. 22 Overvad, T.F., Rasmussen, L.H., Skjoth, F., Overvad, K., Lip, G.Y., Larsen, T.B., Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med 126:640 (2013), e9–e17.
23. 23 Weber, M.A., Neutel, J.M., Smith, D.H., Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol 37 (2001), 169–174.
24. 24 Davos, C.H., Doehner, W., Rauchhaus, M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9 (2003), 29–35.
25. 25 Kalantar-Zadeh, K., Anker, S.D., Horwich, T.B., Fonarow, G.C., Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol 101 (2008), 89E–103E.
26. 26 Novo, G., Mansueto, P., La Franca, M.L., et al. Risk factors, atrial fibrillation and thromboembolic events. Int Angiol 27 (2008), 433–438.
27. 27 Chung, M.K., Martin, D.O., Sprecher, D., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001), 2886–2891.
28. 28 Iwasaki, Y.K., Kato, T., Xiong, F., et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol 64 (2014), 2013–2023.
29. 29 Abed, H.S., Wittert, G.A., Leong, D.P., et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 310 (2013), 2050–2060.
30. 30 Pathak, R.K., Middeldorp, M.E., Meredith, M., et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol 65 (2015), 2159–2169.